Skip to content

XOMA Corporation XOMA Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
Royalty Pharma logo
Royalty PharmaRPRX
Theravance Biopharma logo
Theravance BiopharmaTBPH
Innoviva, Inc. logo
Innoviva, Inc.INVA
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's deferred tax assets and other non-current assets?
XOMA Corporation (XOMA) reported deferred tax assets and other non-current assets of $174K in Q1 2026.
How has XOMA Corporation's deferred tax assets and other non-current assets changed year-over-year?
XOMA Corporation's deferred tax assets and other non-current assets decreased by 90.3% year-over-year, from $1.79M to $174K.
What is the long-term trend for XOMA Corporation's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), XOMA Corporation's deferred tax assets and other non-current assets has grown at a 59.8% compound annual growth rate (CAGR), from $41K to $427K.